Arrowhead Pharmaceuticals, Inc. (ARWR)
62.64
-1.88
(-2.91%)
USD |
NASDAQ |
Feb 09, 16:00
62.70
+0.06
(+0.10%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Market Cap : 8.772B for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 1.919B |
| Eli Lilly & Co. | 935.00B |
| Ionis Pharmaceuticals, Inc. | 13.73B |
| Sanofi | 117.73B |
| Cidara Therapeutics, Inc. | 6.962B |
Market Cap Related Metrics
| PE Ratio | 40.72 |
| PS Ratio | 7.894 |
| Price to Book Value | 15.43 |
| Price to Free Cash Flow | 26.34 |
| Price | 62.64 |
| Earnings Yield | 2.46% |
| Operating PE Ratio | 28.65 |
| Normalized PE Ratio | 40.72 |